Infliximab er udviklet til at binde sig til et kemisk signalmolekyle i kroppen kaldet tumornekrosefaktor- alfa (TNF- alfa).
Infliximab has been designed to bind to a chemical messenger in the body called tumour necrosis factor-alpha (TNF-alpha).